EYPT:NASDAQ, EyePoint Pharmaceuticals, Inc.

EYPT stock overview

EyePoint Pharmaceuticals, Inc. (EYPT:NASDAQ) closed at $3.07 on October 13, 2026, down 7.53% on the day. The stock trades 83.9% below its 52-week high of $19.11 and 0.7% above its 52-week low of $3.05. Over the past year, it lost 76.7%. EyePoint Pharmaceuticals, Inc. is part of the Capital Goods sector (Biotechnology: Laboratory Analytical Instruments).

Key figures

Price: $3.07
Day change: -7.53%
Volume: 2,499,376
Average volume: 4,024,004
Market cap: 257M+
52-week range: $3.05 – $19.11
50-day average: $5.95
200-day average: $12.11

Performance

5D	1M	3M	6M	1Y
-9.71%	-27.76%	-76.46%	-79.44%	-76.67%

Price action over the past year

In 252 trading sessions since October 13, 2025, EYPT closed higher on 121 days (48%). Its best day was September 17, 2026 (+15.65%) and its worst was August 17, 2026 (-66.98%). The stock moved 10% or more in a single session 13 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

Oct 13, 2026: Trading sideways between $3.07 and $3.46 over 14 days (Sideways scanner)
Oct 13, 2026: Down 27.8% over 30 days, from $4.25 (Dips & Crashes scanner)
Oct 13, 2026: Hit a new 52-Week Low of $3.07 (New Highs/Lows scanner)
Sep 16, 2026: News catalyst: Private Placement (News Catalysts scanner)
Aug 14, 2026: Spiked to $14.76 on 2M+ shares (Spikes scanner)

EYPT news

About EyePoint Pharmaceuticals, Inc.

pSivida Corp develops tiny, sustained-release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years.

Similar stocks

Find more stocks like EYPT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.